Sangelaji B, Nabavi SM, Estebsari F, Banshi MR, Rashidian H, Jamshidi E, et al. Effect of combination exercise therapy on walking distance, postural balance, fatigue and quality of life in multiple sclerosis patients: a clinical trial study. Iran Red Crescent Med J. 2014;16(6):e17173.
Article PubMed PubMed Central Google Scholar
Bradley W. Neurology in clinical practice. Philadelphia: Heineman; 2004.
Dastoorpoor M, Zamanian M, Moradzadeh R, Nabavi SM, Kousari RJ. Prevalence of sexual dysfunction in men with multiple sclerosis: a systematic review and meta-analysis. Syst Rev. 2021;10(1):1–9.
Mousavizadeh A, Dastoorpoor M, Naimi E, Dohrabpour K. Time-trend analysis and developing a forecasting model for the prevalence of multiple sclerosis in Kohgiluyeh and Boyer-Ahmad Province, southwest of Iran. Public Health. 2018;154:14–23.
Article CAS PubMed Google Scholar
Kingwell E, Marriott JJ, Jetté N, Pringsheim T, Makhani N, Morrow SA, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol. 2013;13(1):1–13.
Etemadifar M, Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Nasr Z. Estimated prevalence and incidence of multiple sclerosis in Iran. Eur Neurol. 2014;72(5–6):370–4.
Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82(10):1132–41.
Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS. Mult Scler. 2020;26(14):1816–21.
Article PubMed PubMed Central Google Scholar
Heydarpour P, Mohammad K, Yekaninejad MS, Elhami S-R, Khoshkish S, Sahraian MA. Multiple sclerosis in Tehran, Iran: a joinpoint trend analysis. Mult Scler. 2014;20(4):512.
Elhami S-R, Mohammad K, Sahraian MA, Eftekhar H. A 20-year incidence trend (1989–2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology. 2011;36(3):141–7.
Dastoorpoor M, Khodadadi N, Majdinasab N, Soltani M, Ghanbari S. Investigating time-trend of multiple sclerosis incidence and prevalence in Khuzestan Province, southwest of Iran (using exponential smoothing method). Casp J Neurol Sci. 2015;8:104–16.
Nabavi SM, Dastoorpoor M, Majdinasab N, Khodadadi N, Khanjani N, Sekhavatpour Z, et al. Prevalence of sexual dysfunction and related risk factors in men with multiple sclerosis in Iran: a multicenter study. Neurol Ther. 2021;10:711–26.
Article PubMed PubMed Central Google Scholar
Sundström P, Wåhlin A, Ambarki K, Birgander R, Eklund A, Malm J. Venous and cerebrospinal fluid flow in multiple sclerosis: a case–control study. Ann Neurol. 2010;68(2):255–9.
Behrouz M, Hosseini Z, Sedaghat F, Soufi M, Rashidkhani B. The relationship between Food Groups and Multiple Sclerosis diseases: a case–control study in Tehranian adult. J Sch Public Health Inst Public Health Res. 2014;11(3):39–53.
Bagheri M, Fayazi S, Elahi N, Tabesh H, Madjdinasab N. Exposure to tobacco smoke, sunlight, pets and farm animals and multiple sclerosis: a case–control study in Ahvaz (Iran). J Health Syst Res. 2014;9:1311–20.
Solomon AJ, Whitham RH. Multiple sclerosis and vitamin D: a review and recommendations. Curr Neurol Neurosci Rep. 2010;10(5):389–96.
Article CAS PubMed Google Scholar
D’hooghe M, Haentjens P, Nagels G, De Keyser J. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol. 2012;19(4):616–24.
Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev. 2010;9(5):A387–94.
Article CAS PubMed Google Scholar
Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61(4):288–99.
Alkhawajah NM, Aljarallah S, Hussain-Alkhateeb L, Almohaini MO, Muayqil TA. Waterpipe tobacco smoking and other multiple sclerosis environmental risk factors. Neuroepidemiology. 2022;56(2):22–8.
Abdollahpour I, Nedjat S, Sahraian MA, Mansournia MA, Otahal P, van der Mei I. Waterpipe smoking associated with multiple sclerosis: a population-based incident case–control study. Mult Sclerosis J. 2017;23(10):1328–35.
Abdollahpour I, Sormani MP, Nedjat S, Mansournia MA, van der Mei I. The role of nutritional factors during adolescence in multiple sclerosis onset: a population-based incident case–control study. Nutr Neurosci. 2021;24(7):500–7.
Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, et al. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci. 2004;24(6):1521–9.
Article CAS PubMed PubMed Central Google Scholar
Chen GQ, Chen YY, Wang XS, Wu SZ, Yang HM, Xu HQ, et al. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. Brain Res. 2010;1309:116–25.
Article CAS PubMed Google Scholar
Mills JH, Thompson LF, Mueller C, Waickman AT, Jalkanen S, Niemela J, et al. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci. 2008;105(27):9325–30.
Article CAS PubMed PubMed Central Google Scholar
Hedström A, Mowry E, Gianfrancesco M, Shao X, Schaefer C, Shen L, et al. High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies. J Neurol Neurosurg Psychiatry. 2016;87(5):454–60.
Tola M, Granieri E, Malagu S, Caniatti L, Casetta I, Govoni V, et al. Dietary habits and multiple sclerosis. A retrospective study in Ferrara, Italy. Acta Neurol. 1994;16(4):189–97.
Pekmezovic T, Drulovic J, Milenkovic M, Jarebinski M, Stojsavljevic N, Mesaros S, et al. Lifestyle factors and multiple sclerosis: a case–control study in Belgrade. Neuroepidemiology. 2006;27(4):212–6.
Massa J, O’Reilly E, Munger K, Ascherio A. Caffeine and alcohol intakes have no association with the risk of multiple sclerosis. Mult Sclerosis J. 2013;19(1):53–8.
Jahromi SR, Toghae M, Jahromi MJR, Aloosh M. Dietary pattern and risk of multiple sclerosis. Iran J Neurol. 2012;11(2):47.
PubMed PubMed Central Google Scholar
Brisdelli F, D’Andrea G, Bozzi A. Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr Drug Metab. 2009;10(6):530–46.
Article CAS PubMed Google Scholar
Al Wutayd O, Mohamed AG, Saeedi J, Al Otaibi H, Al JM. Environmental exposures and the risk of multiple sclerosis in Saudi Arabia. BMC Neurol. 2018;18(1):1–8.
Casagrande J, Pike M, Smith P. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics. 1978;34:483–6.
Article CAS PubMed Google Scholar
Narain A, Kwok C, Mamas M. Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Clin Pract. 2016;70(10):791–805.
Article CAS PubMed Google Scholar
Conlay LA, Conant JA, Debros F, Wurtman R. Caffeine alters plasma adenosine levels. Nature. 1997;389(6647):136.
Article CAS PubMed Google Scholar
Dehghan M, Ghaedi-Heidari F. Environmental risk factors for multiple sclerosis: a case–control study in Kerman, Iran. Iran J Nurs Midwifery Res. 2018;23(6):431.
Article PubMed PubMed Central Google Scholar
Harirchian M, Bitarafan S, Honarvar N. Dairy products consumption in multiple sclerosis patients: useful or harmful. Int J Neurorehabil. 2016;3:e126.
DeChristopher LR, Uribarri J, Tucker KL. Intake of high fructose corn syrup-sweetened soft drinks, fruit drinks, and apple juice is associated with prevalent coronary heart disease, in US adults, ages 45–59 y. BMC Nutr. 2017;3(1):1–12.
Herden L, Weissert R. The impact of coffee and caffeine on multiple sclerosis compared to other neurodegenerative diseases. Front Nutr. 2018;5:133.
Article PubMed PubMed Central Google Scholar
Menkes DB, Aghajanian GK, McCall RB. The chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleus. Life Sci. 1980;27(1):45–55.
Article CAS PubMed Google Scholar
Cardinali DP. Methylxanthines: possible mechanisms of action in the brain. Trends Pharmacol Sci. 1980;1(2):405–7.
留言 (0)